Associate Professor
Chapman University School of Pharmacy
Irvine, California
Dr. Sumbria is an Associate Professor at Chapman University and an Associate Scientist at UC, Irvine. Dr. Sumbria received her PhD in Pharmaceutical Sciences from the Texas Tech University Health Sciences Center (TTUHSC) in 2010. Dr. Sumbria completed her postdoctoral training at the Department of Medicine, at the University of California, Los Angeles (UCLA), and the Department of Neurology at the University of California, Irvine (UCI) from 2011-2014. At UCLA, Dr. Sumbria focused on CNS drug delivery using receptor-mediated transcytosis for non-invasive delivery of biologics and other large molecular weight therapeutics across the BBB in different experimental models of CNS disorders. At UCI, the focus of her research was studying the role of cerebral microbleeds in cerebrovascular diseases like stroke. Dr. Sumbrias's current research program focuses on CNS drug delivery for Alzheimer's disease (AD), understanding the mechanisms involved in AD pathogenesis, and elucidating non-hemorrhagic mechanisms of cerebral microbleeds. Her work has been funded by several federal and foundation grants, and she is also extensively involved in teaching and mentoring laboratory research personnel and graduate students.
Disclosure information not submitted.
IgG-Fusion Proteins for Alzheimer’s Disease
Tuesday, October 22, 2024
10:00 AM – 10:30 AM MT